logo
Share SHARE
FONT-SIZE Plus   Neg

Threshold Pharma Says FDA Granted Orphan Drug Designation For TH-302

Threshold Pharmaceuticals, Inc. (THLD) announced that the US Food and Drug Administration, or FDA, has granted orphan drug designation for TH-302, a hypoxia-targeted drug, for treating soft tissue sarcoma.

Barry Selick, chief executive officer of Threshold Pharma, stated, "Following our announcement on March 16 regarding the receipt of orphan drug designation in the EU, we are pleased to also have US orphan designation in place. The results of our Phase 2 study (TH-CR-403) in soft tissue sarcoma are certainly supportive of a pivotal trial underway in this difficult to treat cancer."

The company further noted that it is conducting a pivotal Phase 3 study (TH-CR-406) in soft tissue sarcoma comparing TH-302 in combination with doxorubicin against single agent doxorubicin.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Sergey Brin, Google's co-founder, is said to be secretly building a massive airship inside Hangar 2 at the NASA Ames Research Center, Bloomberg reported, citing people with knowledge of the project. As per the report, the craft looks like a zeppelin-like airship, and its not clear whether its a hobby... Boeing Co. (BA) reported a profit for the first-quarter 2017 that increased about 19 percent from last year driven by solid execution on production programs and services. But, quarterly revenues decreased 7.3 percent to $21.0 billion, reflecting the timing of commercial and defense aircraft deliveries. The company raised its 2017 profit guidance. But it maintained its annual revenue guidance. Ride-sharing company Uber Technologies Inc. is partnering with aircraft manufacturers to develop an on-demand network of vertical takeoff and landing vehicles. Uber plans to roll out flying cars with a pilot in the Dallas-Fort Worth area by 2020 and flights in Dubai at Expo2020, Chief Product Officer...
comments powered by Disqus
Follow RTT